Effect of depolymerized holothurian glycosaminoglycan (DHG) on the activation of factor VIII and factor V by thrombin

Journal of Biochemistry

Volumn 119, Issue 1, 1996, Pages 63-69

  Nagase, Hideki ^a   Enjyoji, Kei Ichi ^b   Shima, Midori ^c   Kitazato, Kenji ^a   Yoshioka, Akira ^c   Saito, Hidehiko ^d   Kato, Hisao ^b  

^a TAIHO PHARMACEUTICAL CO LTD   (Japan)

^b NATIONAL CEREBRAL AND CARDIOVASCULAR CENTER   (Japan)

^c NARA MEDICAL UNIVERSITY   (Japan)

^d NAGOYA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Anticoagulant; Factor VIII; Glycosaminoglycan; Holothurian; Thrombin

Indexed keywords

ANTICOAGULANT AGENT; ANTITHROMBIN III; BLOOD CLOTTING FACTOR 5; BLOOD CLOTTING FACTOR 8; BLOOD CLOTTING INHIBITOR; FLUORESCEIN; GLYCOSAMINOGLYCAN; HEPARIN COFACTOR; HOLOTHURIAN GLYCOSAMINOGLYCAN; THROMBIN; THROMBIN INHIBITOR; UNCLASSIFIED DRUG;

ANTICOAGULATION; ARTICLE; BINDING AFFINITY; BLOOD CLOTTING; COMPLEX FORMATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DEPOLYMERIZATION; DISSOCIATION CONSTANT; DRUG EFFECT; IMMUNOBLOTTING; PROTEIN DEGRADATION;

EID: 0030025579     PISSN: 0021924X     EISSN: None     Source Type: Journal    
DOI: 10.1093/oxfordjournals.jbchem.a021217     Document Type: Article

References (37)

1. Suzuki, N., Kitazato, K., Takamatsu, J., and Saito, H. (1991) Antithrombotic and anticoagulant activity of depolymerized fragment of the glycosaminoglycan extracted from Stichopus japonicus Selenka. Thromb. Haemostas. 65, 369-373
2. Nagase, H., Enjyoji, K., Minamiguchi, K., Kitazato, T.K., Kitazato, K., Saito, H., and Kato, H. (1995) Depolymerized holothurian glycosaminoglycan with novel anticoagulant actions: Antithrombin III- and heparin cofactor II-independent inhibition of factor X activation by factor IXa-factor VIIIa complex and heparin cofactor II-dependent inhibition of thrombin. Blood 85, 1527-1534
3. Maffrand, J.P., Herbert, J.M., Bernat, A., Derreyn, G., Delebassee, D., Savi, P., Pinot, J.J., and Sampol, J. (1991) Experimental and clinical pharmacology of pentosan polysulfate. Semin. Thromb. Hemostas. 14, (supplement 2), 186-198
4. Sie, P., Ofosu, F., Fernandez, F., Buchanan, M.R., Petitou, M., and Boneu, B. (1986) Respective role of antithrombin III and heparin cofactor II in the in vitro anticoagulant effect of heparin and of various sulfated polysaccharides. Br. J. Haematol. 64, 707-714
5. Wagenvoord, R., Hendrix, H., Soria, C., and Hemker, H.C. (1988) Localization of the inhibitory site(s) of pentosan polysulfate in blood coagulation. Thromb. Haemostas. 6, 220-225
6. Barrow, R.T., Healey, J,F., and Lollar, P. (1994) Inhibition by heparin of thrombin-catalyzed activation of the factor VIII-von Willebrand factor complex. J. Biol. Chem. 269, 593-598
7. Yoshida, K., Minami, Y., Nemoto, H., Numata, K., and Yamanaka, E. (1992) Structure of DHG, a depolymerized glycosaminoglycan from sea cucumber, Stichopus japonicus. Tetrahedron Lett. 33, 4959-4962
8. Fay, P.J., Haidaris, P.J., and Smudzin, T.M. (1991) Human factor Villa structure. J. Biol. Chem. 266, 8957-8962
9. Dahlback, B. (1980) Human coagulation factor V purification and thrombin-catalyzed activation. J. Clin. Invest. 66, 583-591
10. Thompson, A.R., Enfield, D.L., Ericsson, L.H., Legaz, M.E., and Fenton, J.W., II (1977) Human thrombin: Partial primary structure. Arch. Biochem. Biophys. 178, 356-357
11. Laemmli, U.K. (1970) Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227, 680-685
12. Morrissey, J.H. (1981) Silver stain for proteins in polyacrylamide gels: A modified procedure with enhanced uniform sensitivity. Anal. Biochem. 117, 307-310
13. Shima, M., Scandella, D., Yoshioka, A., Nakai, H., Tanaka, I., Kamisue, S., Terada, S., and Fukui, H. (1994) A factor VIII neutralizing monoclonal antibody and a human inhibitor alloantibody recognizing epitopes in the C2 domain inhibit factor VIII binding to von Willebrand factor and to phosphatidylserine. Thromb. Haemostas. 69, 240-246
14. Kato, H. and Uchida, K. (1988) Automated fluorogenic methods for the evaluation of the extrinsic coagulation reactions in human plasma. Thromb. Res. 50, 77-90
15. Nagasawa, K. and Uchiyama, H. (1978) Preparation and properties of biologically active fluorescent heparins. Biochim. Biophys. Acta 544, 430-440
16. Jordan, R.E., Oosata, G.M., Gardner, W.T., and Rosenberg, R.D. (1980) The binding of low molecular weight heparin to hemostatic enzymes. J. Biol. Chem. 255, 10073-10080
17. Baruch, D., Lindhout, T., and Hemker, H.C. (1986) Inhibition of thrombin-catalized reaction in blood coagulation and platelet activation by heparin fractions in the absence of antithrombin III. Haemostasia 16, 71-81
18. Eaton, D., Rodriguez, H., and Vehar, G.A. (1986) Proteolytic processing of human factor VIII. Correlation of specific cleavages by thrombin, factor Xa, and activated protein C with activation and inactivation of factor VIII coagulant activity. Biochemistry 25, 505-512
19. Lollar, P., Fay, P.J., and Fass, D.N. (1988) Factor VIII and Factor Villa in Methods in Enzymology (Lorand, L. and Mann, K.G., eds.) Vol. 222, pp. 128-143, Academic Press, San Diego
20. Lollar, P., Hill-eubanks, D.C., and Parker, C.G. (1988) Association of the factor VIII light chain with von Willebrand factor. J. Biol. Chem. 263, 10451-10455
21. Kalafatis, M., Krishnaswamy, S., Rand, M.D., and Mann, K.G. (1993) Factor V in Methods in Enzymology (Lorand, L. and Mann, K.G., eds.) Vol. 222, pp. 224-236, Academic Press, San Diego
22. Monkovic, D.D. and Tracy, P.B. (1990) Activation of human factor V by factor Xa and thrombin. Biochemistry 29, 1118-1128
23. Keller, F.G., Ortel, T.L., Quinn-Allen, M.A., and Kane, W.H. (1995) Thrombin-catalyzed activation of recombinant human factor V. Biochemistry 34, 4118-4124
24. Bourin, M.C. and Lindahl, U. (1993) Glycosaminoglycans and the regulation of blood coagulation. Biochem. J. 289, 313-330
25. Barrow, R.T., Parker, E.T., Krishnaswamy, S., and Lollar, P. (1994) Inhibition by heparin of the human blood coagulation intrinsic pathway factor X activator, J. Biol. Chem. 269, 26796-26800
26. Stubbs, M.T. and Bode, W. (1995) The clot thickens: Clues provided by thrombin structure. TIBS 20, 23-28
27. Sheehan, J.P., Tollefsen, D.M., and Sadler, J.E. (1994) Heparin cofactor II is regulated allosterically and not primarily by templated effects. J. Biol. Chem. 269, 32747-32751
28. Sheehan, J.P. and Sadler, J.E. (1994) Molecular mapping of the heparin-binding exocite of thrombin. Proc. Natl. Acad. Sci. USA 91, 5518-5522
29. Olson, S.T., Halvorson, H.R., and Bjork, I. (1991) Quantitative characterization of the thrombin-heparin interaction. Discrimination between specific and nonspecific binding models. J. Biol. Chem. 266, 6342-6352
30. Tanyi, A., Benjamin, V., Sadberry, A.J., and Doctor, V.M. (1995) Fluorescence and circular dichroism studies during the interactions of sulfated polysaccharides with antithrombin III. Thromb. Res. 77, 505-513
31. Beguin, S., Lindhout, T., and Hemker, B.C. (1988) The mode of action of heparin in plasma. Thromb. Haemostas. 60, 457-462
32. Ofosu, F.A., Hirsh, J., Esmon, C.T., Modi, G.J., Smith, L.M., Anvari, N., Buchanan, M.R., Fenton, J.W., and Blajchman, M.A. (1989) Unfractionated heparin inhibits thrombin-catalysed amplification reactions of coagulation more efficiently than those catalyzed by factor Xa. Biochem. J. 257, 143-150
33. Bjork, I. and Lindahl, U. (1982) Mechanism of the anticoagulant action of heparin. Mol. Cell. Biochem. 48, 161-182
34. Scully, M.F., Ellis, V., Seno, N., and Kakkar, V.V. (1986) The anticoagulant properties of mast cell product, chondroitin sulfate E. Biochem. Biophys. Res. Commun. 137, 15-22
35. Buchanan, M.R., Ofosu, F.A., Fernandez, F., and Ryn, J.V. (1986) Lack of relationship between enhanced bleeding induced by heparin and other sulfated polysaccharides and enhanced catalysis of thrombin inhibition. Semin. Thromb. Hemostas. 12, 324-327
36. Barrowcliffe, R.E., Merton, R.E., Gray, E., and Thomas, D.P. (1988) Heparin and bleeding: An association with lipase release. Thromb. Haemostas. 60, 434-436
37. Fernandez, F., Guyen, P.N., Ryn, J.V., Ofosu, F.A., Hirsh, J., and Buchanan, M.R. (1986) Hemorrhagic doses of heparin and other glycosaminoglycans induced a platelet defect. Thromb. Res. 43, 491-495